RA Capital Healthcare Fund LP
CIK 1315082
Transactions on file
204
Open-market buys
67
Win rate (buys)
86%
64 scored
Avg % since filing (buys)
+63.1%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-24 | 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 59,880 | $596.4K | +0.7% | open → |
| 2026-07-24 | 2026-07-22 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 84,124 | $835.4K | +1.0% | open → |
| 2026-07-24 | 2026-07-21 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 120,582 | $1.15M | +5.0% | open → |
| 2026-07-24 | 2026-07-13 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 6,522 | $58.3K | +12.2% | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 336,965 | $3.37M | +12.4% | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 4,918,411 | $49.18M | +12.4% | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 367,427 | $0.00 | — | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 908,103 | $0.00 | — | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 553,703 | $0.00 | — | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 970,950 | $0.00 | — | open → |
| 2026-07-22 | 2026-07-20 | FRNM Freenome, Inc. | Director10% | Grant | 6,561,711 | $0.00 | — | open → |
| 2026-07-22 | 2026-07-22 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 47,250 | $1.41M | +5.1% | open → |
| 2026-07-22 | 2026-07-21 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 37,723 | $1.13M | +4.3% | open → |
| 2026-07-22 | 2026-07-21 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 6,504 | $189.7K | +7.2% | open → |
| 2026-07-22 | 2026-07-21 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 21,696 | $606.6K | +11.9% | open → |
| 2026-07-22 | 2026-07-20 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 32,987 | $914.4K | +12.8% | open → |
| 2026-07-22 | 2026-07-20 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 98,433 | $2.67M | +15.3% | open → |
| 2026-07-21 | 2026-07-16 | VOR Vor Biopharma Inc. | 10% | Sale | 213 | $4.2K | -2.5% | open → |
| 2026-07-21 | 2026-07-16 | VOR Vor Biopharma Inc. | 10% | X | 2,100,000 | $4.2K | +962900.0% | open → |
| 2026-07-20 | 2026-07-17 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 7,882 | $70.5K | +12.1% | open → |
| 2026-07-20 | 2026-07-16 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 152,472 | $1.36M | +12.3% | open → |
| 2026-07-14 | 2026-07-13 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 6,552 | $58.6K | +12.2% | open → |
| 2026-07-14 | 2026-07-10 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 15,102 | $135.5K | +11.8% | open → |
| 2026-06-29 | 2026-06-26 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 1,876 | $16.8K | +11.7% | open → |
| 2026-06-29 | 2026-06-25 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 31,000 | $275.3K | +13.0% | open → |
| 2026-06-22 | 2026-06-17 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 27,695 | $9.7K | +22.0% | open → |
| 2026-06-22 | 2026-06-17 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 389,216 | $136.2K | +22.0% | open → |
| 2026-06-17 | 2026-06-16 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 61,523 | $1.54M | +78.3% | open → |
| 2026-06-17 | 2026-06-15 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 6,146 | $153.0K | +78.9% | open → |
| 2026-06-16 | 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 124,893 | $1.11M | +12.8% | open → |
| 2026-06-16 | 2026-06-15 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 15,414 | $138.6K | +11.6% | open → |
| 2026-06-16 | 2026-06-12 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 391,019 | $3.35M | +17.0% | open → |
| 2026-06-16 | 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 9,939 | $3.7K | +15.4% | open → |
| 2026-06-16 | 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 139,686 | $51.7K | +15.4% | open → |
| 2026-06-16 | 2026-06-15 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 8,554 | $3.3K | +9.5% | open → |
| 2026-06-16 | 2026-06-15 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 120,216 | $46.9K | +9.5% | open → |
| 2026-06-16 | 2026-06-12 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 11,322 | $4.5K | +6.7% | open → |
| 2026-06-16 | 2026-06-12 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 159,119 | $63.6K | +6.7% | open → |
| 2026-06-15 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 1,460,397 | $29.21M | +56.4% | open → |
| 2026-06-15 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | Director10% | Buy | 19,728,353 | $394.57M | +56.4% | open → |
| 2026-06-15 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | Director10% | C | 1,187,881 | $0.00 | — | open → |
| 2026-06-15 | 2026-06-11 | PBLS Parabilis Medicines, Inc. | Director10% | C | 6,556,740 | $0.00 | — | open → |
| 2026-06-13 | 2026-06-11 | JANX Janux Therapeutics, Inc. | Director10% | Grant | 5,500 | $0.00 | — | open → |
| 2026-06-12 | 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 17,437 | $6.6K | +12.4% | open → |
| 2026-06-12 | 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 245,066 | $93.1K | +12.4% | open → |
| 2026-06-12 | 2026-06-10 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 3,051 | $1.1K | +15.4% | open → |
| 2026-06-12 | 2026-06-10 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 42,872 | $15.9K | +15.4% | open → |
| 2026-06-12 | 2026-06-09 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 24,565 | $9.1K | +15.4% | open → |
| 2026-06-12 | 2026-06-09 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 345,235 | $127.7K | +15.4% | open → |
| 2026-06-11 | 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 548,580 | $4.34M | +26.8% | open → |
| 2026-06-11 | 2026-06-10 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 103 | $721.00 | +43.3% | open → |
| 2026-06-11 | 2026-06-09 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 479,039 | $3.31M | +45.2% | open → |
| 2026-06-05 | 2026-06-03 | ABOS Acumen Pharmaceuticals, Inc. | Director10% | Grant | 35,500 | $0.00 | — | open → |
| 2026-05-21 | 2026-05-20 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 996 | $24.8K | +78.5% | open → |
| 2026-05-21 | 2026-05-19 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 3,802 | $94.9K | +78.3% | open → |
| 2026-05-20 | 2026-05-18 | ACRV Acrivon Therapeutics, Inc. | Director10% | Grant | 9,366 | $0.00 | — | open → |
| 2026-05-14 | 2026-05-12 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 6,387 | $159.0K | +78.8% | open → |
| 2026-05-13 | 2026-05-11 | ARTV Artiva Biotherapeutics, Inc. | Director10% | Buy | 6,510,416 | $75.00M | -12.9% | open → |
| 2026-05-12 | 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 6,719 | $4.3K | -33.3% | open → |
| 2026-05-12 | 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 94,432 | $60.4K | -33.3% | open → |
| 2026-05-12 | 2026-05-11 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 5,812 | $3.9K | -36.3% | open → |
| 2026-05-12 | 2026-05-11 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 81,678 | $54.7K | -36.3% | open → |
| 2026-05-12 | 2026-05-08 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 25,012 | $17.8K | -39.9% | open → |
| 2026-05-12 | 2026-05-08 | HOWL Werewolf Therapeutics, Inc. | 10% | Sale | 351,514 | $249.6K | -39.9% | open → |
| 2026-05-11 | 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 25,720 | $643.0K | +78.1% | open → |
| 2026-05-11 | 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 14,149 | $346.2K | +82.0% | open → |
| 2026-05-11 | 2026-05-08 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 1,483 | $37.0K | +78.3% | open → |
| 2026-05-11 | 2026-05-07 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 1,985 | $49.5K | +78.5% | open → |
| 2026-05-11 | 2026-05-07 | COAG Hemab Therapeutics Holdings, Inc. | 10% | Buy | 7,921 | $192.8K | +82.9% | open → |
| 2026-04-28 | 2026-04-27 | PRLD Prelude Therapeutics Inc | 10% | Other | 1,407,000 | $0.00 | — | open → |
| 2026-04-24 | 2026-04-22 | VOR Vor Biopharma Inc. | Director10% | Sale | 165,150 | $2.60M | +22.1% | open → |
| 2026-04-23 | 2026-04-22 | ACRV Acrivon Therapeutics, Inc. | Director10% | Grant | 3,888,888 | $7.00M | -11.1% | open → |
| 2026-04-21 | 2026-04-20 | VOR Vor Biopharma Inc. | Director10% | Sale | 171,963 | $2.71M | +22.1% | open → |
| 2026-04-21 | 2026-04-17 | VOR Vor Biopharma Inc. | Director10% | Sale | 458,411 | $7.46M | +18.3% | open → |
| 2026-04-15 | 2026-04-15 | VOR Vor Biopharma Inc. | Director10% | Sale | 53,644 | $858.8K | +20.3% | open → |
| 2026-04-15 | 2026-04-14 | VOR Vor Biopharma Inc. | Director10% | Sale | 153,735 | $2.46M | +20.6% | open → |
| 2026-04-15 | 2026-04-13 | VOR Vor Biopharma Inc. | Director10% | Sale | 530,610 | $8.57M | +19.3% | open → |
| 2026-04-13 | 2026-02-20 | ACET Adicet Bio, Inc. | 10% | Buy | 74,751 | $543.4K | +17.9% | open → |
| 2026-04-13 | 2026-02-19 | ACET Adicet Bio, Inc. | 10% | Buy | 74,268 | $535.5K | +18.9% | open → |
| 2026-04-13 | 2026-02-18 | ACET Adicet Bio, Inc. | 10% | Buy | 74,577 | $525.0K | +21.7% | open → |
| 2026-04-10 | 2026-04-10 | VOR Vor Biopharma Inc. | Director10% | Sale | 828 | $13.0K | +22.3% | open → |
| 2026-04-10 | 2026-04-09 | VOR Vor Biopharma Inc. | Director10% | Sale | 135,201 | $2.24M | +16.1% | open → |
| 2026-04-10 | 2026-04-08 | VOR Vor Biopharma Inc. | Director10% | Sale | 130,862 | $2.21M | +13.9% | open → |
| 2026-04-10 | 2026-04-08 | VOR Vor Biopharma Inc. | Director10% | Sale | 353,242 | $5.76M | +18.0% | open → |
| 2025-02-03 | 2025-01-30 | ETNB 89bio, Inc. | Director10% | Buy | 5,714,285 | $50.00M | — | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director10% | Buy | 102,414 | $1.84M | +153.9% | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director10% | Buy | 1,022,586 | $18.41M | +153.9% | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director10% | C | 179,975 | — | — | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director10% | C | 2,222,084 | — | — | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director10% | C | 5,021,990 | — | — | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director10% | C | 527,444 | — | — | open → |
| 2025-03-07 | 2025-03-05 | JANX Janux Therapeutics, Inc. | Director10% | Buy | 37,455 | $1.17M | -51.0% | open → |
| 2025-03-07 | 2025-03-05 | JANX Janux Therapeutics, Inc. | Director10% | Buy | 304,287 | $9.30M | -49.8% | open → |
| 2025-03-07 | 2025-03-07 | JANX Janux Therapeutics, Inc. | Director10% | Buy | 110,206 | $3.42M | -50.6% | open → |
| 2025-03-07 | 2025-03-06 | JANX Janux Therapeutics, Inc. | Director10% | Buy | 372,093 | $11.45M | -50.2% | open → |
| 2025-03-17 | 2025-03-13 | MLYS Mineralys Therapeutics, Inc. | Director | Buy | 1,296,296 | $17.50M | +97.9% | open → |
| 2025-04-30 | 2025-04-28 | JBIO Jade Biosciences, Inc. | 10% | Other | 1,062,326 | — | — | open → |
| 2025-05-14 | 2025-05-12 | HOWL Werewolf Therapeutics, Inc. | Director10% | Buy | 320,913 | $276.0K | -50.3% | open → |
| 2025-05-14 | 2025-05-14 | HOWL Werewolf Therapeutics, Inc. | Director10% | Buy | 162,539 | $159.3K | -56.4% | open → |
| 2025-05-14 | 2025-05-13 | HOWL Werewolf Therapeutics, Inc. | Director10% | Buy | 52,974 | $51.9K | -56.4% | open → |
